Walking a gadolinium tightrope of perception & bottom line March 22, 2017 -- The recommendation by the European Medicines Agency on 10 March that market authorization for four linear gadolinium contrast agents be suspended shocked the radiology community, but what will be the business repercussions? Analyst Stephen Holloway gives his assessment.
Deep learning offers promise for prostate MRI reads March 22, 2017 -- Deep-learning software can outperform a nondeep-learning method that's been used previously in computer-aided detection software and may be able to help radiologists differentiate between prostate cancer and benign conditions on MRI, according to research presented this month at ECR 2017.
Mobile App Spotlight: A k-Space Odyssey March 21, 2017 -- AuntMinnie.com presents the next article in an ongoing series highlighting notable mobile apps in radiology. In this installment, we take a look at A k-Space Odyssey, an iOS app designed to facilitate understanding of k-space, the mathematical abstraction that connects MRI scan parameters with the clinical image.
No signal intensity for pediatric patients with macrocyclic GBCA March 17, 2017 -- German researchers have found additional evidence that the use of a macrocyclic gadolinium-based contrast agent (GBCA) for MRI scans does not increase signal intensity in the dentate nucleus. The new findings come from a study of pediatric patients published online in Radiology.
Gadolinium contrast: Farewell to well-known brands March 15, 2017 -- The long wait is over for the European Medicines Agency (EMA) investigation into gadolinium contrast agents. Its noncommittal verdict punishes all manufacturers, though some are given a sweetener, but it does not shed a complimentary light upon EMA, writes the Maverinck.
Dutch scoop top ECR prize for breast MRI work March 14, 2017 -- A new method may help improve delineation between malignant and benign breast lesions on breast MR images, according to researchers from the University of Groningen in the Netherlands. The group won a prestigious magna cum laude award at ECR 2017 in Vienna for its work.
Pull linear MRI contrast from market, European group says March 10, 2017 -- In a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.
Does breast MRI hold future for mammography market? March 8, 2017 -- Clinical evidence supporting the use of MRI for breast imaging is growing in volume and credibility. Further research is required, but evidence suggests MRI has a significant future role to play. So why have we seen little or no commercial impact from breast MRI? Market analyst Stephen Holloway reports.
Top 5 trends from ECR 2017 in Vienna March 7, 2017 -- The stunning flower-and-skull display that formed the centerpiece of ECR 2017 certainly looked impressive in everybody's photos, on social media, and in the daily newspaper. But what were the truly lasting impressions and meaningful issues to take away from this year's congress in Vienna? Our editorial team has put together a list of five key themes.
MRI monitors fat for bariatric surgery March 5, 2017 -- VIENNA - MRI and spectroscopy can accurately measure fat volumes in bariatric patients before and after surgery, according to the results of a German study presented at ECR 2017 on Saturday.